Cargando…
Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis: Results of a Population-Based Study
OBJECTIVE—: Chemerin has been shown to be associated with inflammation and metabolic syndrome, which are in turn leading risk factors for atherosclerosis. A few clinical studies have concentrated on the role of chemerin in atherosclerosis but revealed divergent findings. Therefore, we aimed to inves...
Autores principales: | Zylla, Stephanie, Dörr, Marcus, Völzke, Henry, Schminke, Ulf, Felix, Stephan B., Nauck, Matthias, Friedrich, Nele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039419/ https://www.ncbi.nlm.nih.gov/pubmed/29853566 http://dx.doi.org/10.1161/ATVBAHA.118.311219 |
Ejemplares similares
-
Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
por: Levin, Lena-Maria, et al.
Publicado: (2019) -
Association of plasma chemerin with all-cause and disease-specific mortality – results from a population-based study
por: Noppes, Katharina, et al.
Publicado: (2023) -
L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP)
por: Bahls, Martin, et al.
Publicado: (2015) -
Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
por: Masuch, Annette, et al.
Publicado: (2018) -
Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)